Ignite Creation Date:
2024-05-06 @ 1:09 PM
Last Modification Date:
2024-10-26 @ 1:09 PM
Study NCT ID:
NCT03944356
Status:
UNKNOWN
Last Update Posted:
2022-08-26
First Post:
2019-04-26
Brief Title:
BRAF-MEK-Inhibition With Dabrafenib and Trametinib in Melanoma Patients
Sponsor:
EuMelaReg gGmbH
Organization:
EuMelaReg gGmbH
Organization Data
Organization:
EuMelaReg gGmbH
Class:
INDUSTRY
Study ID:
EUMR-18001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
EuMelaReg gGmbH
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None